Maternal and neonatal outcomes in singleton pregnancies conceived using donor oocytes: a retrospective cohort study
In singleton gestations conceived using assisted reproductive technology, donor oocyte use does not appear to be associated with an increased risk of adverse maternal or neonatal outcomes. This may be reassuring for patients hoping to achieve a live birth through use of donor oocytes.
Authors
- Moti Gulersen (ORCID: https://orcid.org/0000-0002-1966-9578)
- David Krantz (ORCID: https://orcid.org/0000-0003-2310-6003)
- Robyn A. Frankel
- Burton Rochelson (ORCID: https://orcid.org/0000-0002-6736-1105)
- Christine Mullin (ORCID: https://orcid.org/0000-0002-3295-7275)
- Eran Bornstein (ORCID: https://orcid.org/0000-0002-2603-8272)
- Randi H. Goldman (ORCID: https://orcid.org/0000-0002-6221-9927)
- Alexandra Peyser (ORCID: https://orcid.org/0000-0001-7516-9810)
- Xueying Li (ORCID: https://orcid.org/0000-0003-1984-3609)
- Amanda Ferraro
Institutions
- European Organisation for Rare Diseases (FR)
- Hofstra University (US)
- North Shore University Hospital (US)
- Lenox Hill Hospital (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
Publication Details
- Journal
- Maternal Health Neonatology and Perinatology
- Published
- 2025-11-09
- DOI
- https://doi.org/10.1186/s40748-025-00212-z
- Primary Topic
- Assisted Reproductive Technology and Twin Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00